$AGLE Next Target PTs 1-1.50 and higherAeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.
SYRE trade ideas
Aeglea BioTherapeutics due for a fat recovery. AGLEIn percentage terms anyway.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
Market Alpha Stock WatchlistNASDAQ:AGLE
Symbol came up on our watchlist scanner. If anyone is watching this one here are some levels.
$AGLE - AEGLEA BIOTHERAPEUTICS INC // LONG$AGLE is in an uptrend and bounced nicely around .618. Going Forward, this should act as key support.
Stop-loss and targets are given in the chart.
Relatively good time to buy because of supportAfter the stock dips to around $6.6, it will bounce up.
KALV - Fallen angel breakout long from $9.57 to $14.33KALV seems breaking out after a long sidewise movement. Recently it had a good breakout & now seems getter ready for a break again.
It also has some insider buying. We think it will continue upward from its current label.
* Trade Criteria *
Date First Found- December 26, 2017
Pattern/Why- Buying support. Fallen angel breakout
Entry Target Criteria- Current price ($9.57)
Exit Target Criteria- $14.33
Stop Loss Criteria- $8.43
Indicator Notes- Bouncing off its MA 100
Special Note- Very big insider buying
Please check back for Trade updates. (Note: Trade update is little delayed here.)
AGLE - Bump & Run formation Long from $5.32/$5.71 to $7.27AGLE seems breaking out of an upward channel formation like the Pharmaceutical sector itself. It has good insider buying.
We think it has very good upward potential.
* Trade Criteria *
Date First Found- December 26, 2017
Pattern/Why- Downward channel breakout, Bump & Run formation
Entry Target Criteria- Pullback to $5.32 or break above $5.71
Exit Target Criteria- 1st Target $7.27, 2nd Target $9.67
Stop Loss Criteria- $4.74
Indicator Notes- Crossed above its MA lines
Special Note- Very good insider buying
Please check back for Trade updates. (Note: Trade update is little delayed here.)
Idea for AGLEOn va essayer de chercher la résistance + étoile doji haussière après micro tendance baissière, retournement ? Je le pense !
